We are very excited to launch our new website! Please take a few moments to click around and explore. Best wishes for 2018!
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...